French pharma exec says he lied to FDA in attempt to steal a Novartis weight loss drug
All signs point to a busy year for M&A, as several pharma chiefs have made clear they’re on the prowl for new science. However, one …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
